Filing Details

Accession Number:
0001209191-10-034130
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-14 13:00:00
Reporting Period:
2010-06-10
Filing Date:
2010-06-14
Accepted Time:
2010-06-14 20:47:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
353569 Quidel Corp QDEL In Vitro & In Vivo Diagnostic Substances (2835) 942573850
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1406652 C Douglas Bryant 10165 Mckellar Court
San Diego CA 92121
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-06-10 20,000 $10.68 165,769 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The weighted average purchase price for these transactions was $10.682301 per share, with a range of $10.606 to $10.75 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.